Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs

Patent Law

: Patent Docs

Teva CEO Predicts Passage of Follow-on Biologics Bill in 2009

By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry

By Donald Zuhn --In November, we noted that the nation's largest mail order pharmacy, Franklin Lakes, NJ-based Medco Health Solutions, Inc., had announced that consumers could expect to see the establishment of a follow-on biologics regulatory pathway in the United States by 2011 (see "Medco Predicts Follow-on Biologics Regulatory Pathway by 2011"). Medco also announced that if Congress could meet such a timeline, more than $34 billion worth of biogeneric drugs could become available in this country between 2013-2017 (the company's calculations included a two-year interval for follow-on biologics to become available after innovator patent rights expire). Last week, Reuters...

Full post as published by Patent Docs on January 02, 2009 (boomark / email).